Crossmark

Medical outcomes after canal wall-down mastoidectomy, external ear canal reconstruction, tympanoplasty, and mastoid obliteration for extensive cholesteatoma

Crossref DOI link: https://doi.org/10.1007/s00405-026-10042-0

Published Online: 2026-01-23

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luntz, Michal

Hod, Keren

Barzilai, Roni https://orcid.org/0000-0002-7027-4221
Funding

Funding for this research was provided by:

Technion - Israel Institute of Technology
License Information

Text and Data Mining valid from 2026-01-23

Version of Record valid from 2026-01-23
More Information

Article History

Received: 18 September 2025

Accepted: 23 January 2026

First Online: 23 January 2026

Declarations

:

: Michal Luntz received honoraria from Bonalive Biomaterials Ltd. for one company-organized course and reimbursement for travel expenses for that course and an additional one.

Document is current

Any future updates will be listed below